On Invalid Date, Goodrx Holdings (NASDAQ: GDRX) reported Q4 2023 earnings per share (EPS) of -$0.06, up 500% year over year. Total Goodrx Holdings earnings for the quarter were -$25.87 million. In the same quarter last year, Goodrx Holdings's earnings per share (EPS) was -$0.01.
As of Q2 2024, Goodrx Holdings's earnings has grown year over year. Goodrx Holdings's earnings in the past year totalled -$8.87 million.
What is GDRX's earnings date?
Goodrx Holdings's earnings date is Invalid Date. Add GDRX to your watchlist to be reminded of GDRX's next earnings announcement.
What was GDRX's revenue last quarter?
On Invalid Date, Goodrx Holdings (NASDAQ: GDRX) reported Q4 2023 revenue of $196.64 million up 6.81% year over year. In the same quarter last year, Goodrx Holdings's revenue was $184.11 million.
What was GDRX's revenue growth in the past year?
As of Q2 2024, Goodrx Holdings's revenue has grown -2.12% year over year. This is 14.25 percentage points lower than the US Health Information Services industry revenue growth rate of 12.13%. Goodrx Holdings's revenue in the past year totalled $750.27 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.